Zobrazeno 1 - 10
of 31
pro vyhledávání: '"B. de La Giclais"'
Publikováno v:
Médecine du Sommeil. 13:122-127
Resume La navigation en solitaire en course au large a la voile requiert, d’un point de vue recuperation, l’organisation d’un sommeil polyphasique. Les episodes de sommeil repartis au cours du nycthemere se doivent d’etre aussi courts que pos
Publikováno v:
Revue Française d'Allergologie. 56:332-333
Publikováno v:
Pharmacopsychiatry. 31:14-18
The effects of zolpidem 10 mg, flunitrazepam 1 mg, and placebo, administrated at bedtime, were studied in 12 healthy male insomniac patients. The assessments included polygraphic sleep recordings during the night and a battery of cognitive tests (sig
Publikováno v:
Revue Française d'Allergologie. 56:332
Publikováno v:
Revue des Maladies Respiratoires. 33:A11
Introduction Les acariens representent la premiere cause d’allergie respiratoire en France. Malgre le lien documente entre rhinite allergique (RA) et degradation de la qualite de vie, il n’existe a notre connaissance aucune donnee specifique de l
Autor:
M R, Boisseau, B, de La Giclais
Publikováno v:
Clinical hemorheology and microcirculation. 31(1)
Disturbances in haemodynamic, biochemical and enzymatic factors have been observed in chronic venous diseases (CVD). These changes lead to the development of varices, telangiectasies and skin disorders. They affect vessels, blood, skin tissues and ce
Autor:
A. Montesano, Rosalia Silvestri, F. Ferrillo, C. Borghi, R. Di Perri, B. de La Giclais, G. Rosadini, R. Massetani, Luigi Murri
Rebound insomnia is a transient intense worsening of sleep usually appearing within 3 days from the abrupt discontinuation of benzodiazepines (mainly short-acting), following long term use and abuse of these hypnotics. Zolpidem is an imidazopyridine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e38e7158772a0ce827570724324d21f
http://hdl.handle.net/11570/1893017
http://hdl.handle.net/11570/1893017
Publikováno v:
Vigilance et transports ISBN: 9782729705138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fb7deb6722345a4ebe937a70a07adbd
https://doi.org/10.4000/books.pul.39642
https://doi.org/10.4000/books.pul.39642
Publikováno v:
Pharmacopsychiatry. 27(4)
In a parallel-group, placebo-controlled, polysomnographic study with randomization, the possible occurrence of rebound insomnia was evaluated in 24 patients suffering from moderate to severe chronic insomnia and receiving either triazolam 0.5 mg, zol
Publikováno v:
Neurophysiologie Clinique/Clinical Neurophysiology. 26:433-434